Talactoferrin Immunotherapy in Metastatic Renal Cell Carcinoma: A Case Series of Four Long-Term Survivors

Talactoferrin alfa (also known as recombinant human lactoferrin, rhLF) is a novel immunomodulatory protein that has previously demonstrated anti-tumor properties in animal models. Following a successful phase I trial, it was administered orally to patients with metastatic renal cell carcinoma (RCC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Mark A., Hayes, Teresa G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194025/
https://www.ncbi.nlm.nih.gov/pubmed/22043271
http://dx.doi.org/10.4021/jocmr499w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194025/
https://www.ncbi.nlm.nih.gov/pubmed/22043271
http://dx.doi.org/10.4021/jocmr499w

Ejemplares similares